Medigus Ltd. Series C Warrant
MDGSW
MDGSW was delisted on the 19th of July, 2023.
4 hedge funds and large institutions have $1.8M invested in Medigus Ltd. Series C Warrant in 2019 Q2 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 4 → 4 (0)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
30% less capital invested
Capital invested by funds: $2.59M → $1.8M (-$784K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$7.76K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$2.6K |
MDGSW Hedge Fund Activity: Q2 2019 in Review
4 of the 4,625 institutional investors tracked by Wall St. Rank reported a position in Medigus Ltd. Series C Warrant (MDGSW) for Q2 2019, worth a combined $1.8M — down 30% from $2.59M a quarter earlier.
Fund positioning in MDGSW was balanced in Q2 2019: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was Sabby Management, adding an estimated $7.76K. The largest seller was Anson Funds Management, cutting an estimated $2.6K.
- 4 institutional investors held Medigus Ltd. Series C Warrant (MDGSW) as of Q2 2019, unchanged from Q1 2019.
- Funds reported $1.8M of Medigus Ltd. Series C Warrant stock for Q2 2019, down 30% quarter-over-quarter.
- 0 funds opened new Medigus Ltd. Series C Warrant positions in Q2 2019 and 0 closed out.
- The largest Medigus Ltd. Series C Warrant buyer in Q2 2019 was Sabby Management, an estimated $7.76K added.
- The largest Medigus Ltd. Series C Warrant seller in Q2 2019 was Anson Funds Management, an estimated $2.6K sold.
Based on aggregated 13F filings for Q2 2019.